All news on the topic: Vemour Investments Limited

469
From Arbidol to Tirzetta: how Russian pharma businessman Petr Bely is building a pharmaceutical empire on drugs with questionable efficacy
Dollar billionaire Petr Bely, owner of the company “Promomed,” has come under scrutiny after launching the weight-loss drug “Tirzetta” on the Russian market, despite reports that it had only been tested on laboratory rats.